Valeant Pharmaceuticals

4 pages

Health Valeant Stock Was Having a Pretty Good 2018—Until Today
BYSy Mukherjee
June 18, 2018
Finance Valeant Is Paying to Get Rid of Its $1 Billion ‘Female Viagra’ Acquisition
BYJen Wieczner
November 7, 2017
Tech A New ICO Wants to Get That Wu-Tang Album Out of Martin Shkreli’s Hands
BYDavid Z. Morris
September 25, 2017
Finance Joe Biden Spars With Bill Ackman
BYDavid Z. Morris
June 24, 2017
Finance Bill Ackman Lost $7.7 Million Per Day on Valeant Stock
BYJen Wieczner
March 15, 2017
Finance Valeant’s Debt Refinance Will Go On Without Bill Ackman
BYReuters
March 14, 2017

Finance Bill Ackman’s Valeant Exit Is an Enormous Loss for the Faded Hedge Fund Star
BYStephen Gandel
March 13, 2017
Health This Investor Says Hedge Funds’ Bets on Valeant Were Worse Than Enron
BYSy Mukherjee
November 17, 2016
Health Valeant Is Being Sued Over the ‘Female Viagra’ Pill
BYReuters
November 3, 2016
Finance Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO
BYReuters
August 22, 2016
Health T. Rowe Price Sues Valeant Over Alleged Fraud
BYSy Mukherjee
August 18, 2016
Finance Valeant’s Troubles Aren’t Driving It To Lower Drug Prices
BYJen Wieczner
August 9, 2016
Health New Valeant CEO Meets Investors Amid Company Struggles
BYReuters
June 14, 2016
Features Yellen Speaks, California Votes, and Valeant Reports—5 Things to Look For in the Week Ahead
BYTom Huddleston Jr.
June 5, 2016
Finance Valeant’s Former CEO Will Stay on as an $83,000-a-Month Consultant
BYLucinda Shen
May 31, 2016

Most Popular

1 - 15 of 60 results